Trending Now
Onconova Therapeutics Inc (NASDAQ:ONTX) Inducts Three Patients In The Phase 1...
Onconova Therapeutics Inc (NASDAQ:ONTX) announced three patients' recruitment by its partner - HanX Biopharmaceuticals, in the second cohort of Phase 1 clinical studies of...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Vaxart Inc. (NASDAQ: VXRT) says it Has Raised Gross Proceeds of...
Vaxart Inc. (NASDAQ:VXRT) will be able to smoothly continue with the clinical and preclinical development of its product candidates. This will be facilitated by...
MAKE IT MODERN
LATEST REVIEWS
BioMarin Pharmaceuticals Inc. (NASDAQ: BMRN) Announce Publication of Valoctocogene Roxaparvovec Study...
BioMarin Pharmaceuticals Inc. (NASDAQ: BMRN) has announced the publication of Phase 3 GENEr8-1 study results of valoctocogene roxaparvovec in the New England Journal of...
MAKE IT MODERN
PERFORMANCE TRAINING
Cannabis Stocks Show Fresh Life Following Corrective Dip (TLRY, CRLBF, MEDH, SNDL, GRWG, APHA)
Pot stocks have been pulling back after Aphria Inc (NASDAQ:APHA) posted less than spectacular results earlier this week. That helped to break...
Agenus Inc (NASDAQ: AGEN) Inks Licensing Deal With Bristol-Myers Squibb Co (NYSE: BMY) To...
Agenus Inc (NASDAQ: AGEN) has partnered with Bristol-Myers Squibb Co (NYSE: BMY). As part of the agreement, Bristol Myers Squibb Co will study an...
High-frequency trading during the holiday season
There always exists a conflict between investors and traders. One extracts inefficiencies in transactions while the other attempts to define value. Technological...
Moderna Inc. (NASDAQ: MRNA) Announce Phase 2 EPICCURE Study Results Evaluating mRNA Therapeutics For...
Moderna Inc. (NASDAQ: MRNA) has announced positive results from the Phase 2 (EPICCURE) study led by AstraZeneca. The study is evaluating mRNA Therapeutics use...
Titan Pharmaceuticals Inc. (NASDAQ:TTNP) Releases Q1 2020 Results And Updates of Its Expansion Of...
Titan Pharmaceuticals Inc. (NASDAQ:TTNP) has announced its Q1 2020 financial results and provided operational updates.
Titan Pharmaceuticals reports revenue of $1.3 million in Q1
The company...
MAKE IT MODERN
